Literature DB >> 12902624

Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy.

Inga Prokopenko1, Cristina Montomoli, Raffaela Ferrai, Luigina Musu, Maria Luisa Piras, Anna Ticca, Bruno S Murgia, Luisa Bernardinelli.   

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory, disabling disease of the central nervous system, known for its complex interplay between genetic and environmental factors. We used life table techniques to calculate age-adjusted recurrence risks for different categories of relatives of MS patients from Central Sardinia (Italy), a genetically homogeneous, stable population with a high degree of consanguinity. We included 313 probands and a total of 12,717 relatives in the analysis. The overall age-adjusted recurrence risk for relatives of MS probands is 1.90% [95% confidence interval (CI): 1.57-2.30]. The age-adjusted recurrence risk in parents was 1.26% (95% CI 0.60-2.63), in children 2.33% (95% CI 0.09-5.56), in sibs 4.76% (95% CI 3.57-6.32), in second-degree relatives 0.72% (95% CI 0.42-1.22), and in third-degree relatives 1.79% (95% CI 1.27-2.51). The sex of the probands (male) and of the relatives (female), and the number of affected relatives in the family significantly increase the risk of MS in relatives. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12902624     DOI: 10.1159/000071192

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis.

Authors:  T Gabelic; D P Ramasamy; B Weinstock-Guttman; J Hagemeier; C Kennedy; R Melia; D Hojnacki; M Ramanathan; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

2.  What role for genetics in the prediction of multiple sclerosis?

Authors:  Stephen Sawcer; Maria Ban; James Wason; Frank Dudbridge
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

3.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.

Authors:  Nadja Borisow; Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr; Kerstin Hellwig
Journal:  EPMA J       Date:  2012-06-22       Impact factor: 6.543

4.  Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.

Authors:  Helga Westerlind; Ryan Ramanujam; Daniel Uvehag; Ralf Kuja-Halkola; Marcus Boman; Matteo Bottai; Paul Lichtenstein; Jan Hillert
Journal:  Brain       Date:  2014-01-17       Impact factor: 13.501

5.  Multiple sclerosis in Kenya: Demographic and clinical characteristics of a registry cohort.

Authors:  Imran Jamal; Jasmit Shah; Peter Mativo; Juzar Hooker; Mitchell Wallin; Dilraj Singh Sokhi
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-06-14

6.  The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.

Authors:  Francesco Fera; Luca Passamonti; Antonio Cerasa; Maria Cecilia Gioia; Maria Liguori; Ida Manna; Paola Valentino; Aldo Quattrone
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

7.  Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.

Authors:  Sharareh Eskandarieh; Narges Sistany Allahabadi; Malihe Sadeghi; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2018-02-07       Impact factor: 2.474

8.  Association between the ACCN1 gene and multiple sclerosis in Central East Sardinia.

Authors:  Luisa Bernardinelli; Salvatore Bruno Murgia; Pier Paolo Bitti; Luisa Foco; Raffaela Ferrai; Luigina Musu; Inga Prokopenko; Roberta Pastorino; Valeria Saddi; Anna Ticca; Maria Luisa Piras; David Roxbee Cox; Carlo Berzuini
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.